For anti-cancer CD8+ T cells, LPP1 and LPP2 did not demonstrate significance or a consistent trend across the three cohorts, but for the high LPP3-expressing tumors, CD8+ T cells were slightly elevated compared with the low LPP3-expressing tumors (all p < 0.001, Figure S5A). Here, CD8A is linked to cancer.